Keith Flaherty

Keith Flaherty is director of Developmental Therapeutics at the Massachusetts General Hospital Cancer Center and associate professor of medicine at Harvard Medical School. He was previously a professor of medicine at the University of Pennsylvania. He is known for his research on targeted therapies for cancer, and in particular for his work on the melanoma drug vemurafenib. In 2013, Massachusetts General Hospital partnered with AstraZeneca to partner Flaherty's research into developing a formula to identify vulnerabilities of tumors with AstraZeneca's library of drugs.

Contents

• Dr keith flaherty genetics of cancer targeted therapies and clinical trials
• Keith flaherty hitting philly bandits 2015 www playinschool com
• References